Mechanisms for Flexibility in DNA Sequence Recognition and VP16-Induced Complex Formation by the Oct-1 POU Domain

REFERENCES

• apRhys, C. M., D. M. Ciufo, E. A. O'Neill, T. J. Kelly, and G. S. Hayward. 1989. Overlapping octamer and TAAGARAT motifs in the VF65-response elements in the herpes simplex virus immediate-early promoters represent independent binding sites for cellular nuclear factor III. J. Virol. 63:2798–2812.
   PubMedGoogle Scholar
• Assa-Munt, N., R. J. Mortishire-Smith, R. Aurora, W. Herr, and P. E. Wright. 1993. The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage l DNA-binding domain. Cell 73:193–205.
   PubMedGoogle Scholar
• Aurora, R. 1992. Ph.D. thesis. State University of New York, Stony Brook.
   Google Scholar
• Aurora, R., and W. Herr. 1992. Segments of the POU domain influence one another's DNA-binding specificity. Mol. Cell. Biol. 12:455–467.
   PubMedGoogle Scholar
• Baumruker, T., R. Sturm, and W. Herr. 1988. OBP100 binds remarkably degenerate octamer motifs through specific interactions with flanking sequences. Genes Dev. 2:1400–1413.
   PubMedGoogle Scholar
• Botfield, M. C., A. Jansco, and M. A. Weiss. 1992. Biochemical characterization of the Oct-2 POU domain with implications for bipartite DNA recognition. Biochemistry 31:5841–5848.
   PubMedGoogle Scholar
• Botfield, M. C., A. Jansco, and M. A. Weiss. 1994. Mapping critical residues in eukaryotic DNA-binding proteins: a plasmid-based genetic selection strategy with application to the Oct-2 POU motif. Biochemistry 33:6177–6185.
   PubMedGoogle Scholar
• Cleary, M., and W. Herr. Unpublished data.
   Google Scholar
• Cleary, M. A., S. Stern, M. Tanaka, and W. Herr. 1993. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. Genes Dev. 7:72–83.
   PubMedGoogle Scholar
• Dekker, N., M. Cox, R. Boelens, C. P. Verrijzer, P. C. van der Vliet, and R. Kaptein. 1993. Solution structure of the POU-specific DNA-binding domain of Oct-1. Nature (London) 362:852–855.
   PubMedGoogle Scholar
• Ebright, R. H. 1991. Identification of amino-acid–base pair contacts by genetic methods. Methods Enzymol. 208:620–640.
   PubMedGoogle Scholar
• Gerster, T., and R. G. Roeder. 1988. A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins. Proc. Natl. Acad. Sci. USA 85:6347–6351.
   PubMedGoogle Scholar
• Herr, W. 1992. Oct-1 and Oct-2: differential transcriptional regulation by proteins that bind to the same DNA sequence, p. 1103–1135. In S. L. McKnight, and K. Yamamoto (ed.), Transcriptional regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, and H. R. Horvitz. 1988. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513–1516.
   PubMed Web of Science ®Google Scholar
• Ingraham, H. A., S. E. Flynn, J. W. Voss, V. R. Albert, M. S. Kapiloff, L. Wilson, and M. G. Rosenfeld. 1990. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1–Pit-1 interactions. Cell 61:1021–1033.
   PubMed Web of Science ®Google Scholar
• Jansco, A., M. C. Botfield, L. C. Sowers, and M. A. Weiss. 1994. An altered-specificity mutation in a human POU domain demonstrates functional analogy between the POU-specific subdomain and phage l repressor. Proc. Natl. Acad. Sci. USA 91:3887–3891.
   PubMedGoogle Scholar
• Klemm, J. D., M. A. Rould, R. Aurora, W. Herr, and C. O. Pabo. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21–32.
   PubMed Web of Science ®Google Scholar
• Kristie, T. M., J. H. LeBowitz, and P. A. Sharp. 1989. The octamer-binding proteins form multi-protein–DNA complexes with the HSV αTIF regulatory protein. EMBO J. 8:4229–4238.
   PubMedGoogle Scholar
• Kristie, T. M., and P. A. Sharp. 1990. Interactions of the Oct-1 POU sub-domains with specific DNA sequences and with the HSV α-trans-activator protein. Genes Dev. 4:2383–2396.
   PubMedGoogle Scholar
• Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367–382.
   PubMed Web of Science ®Google Scholar
• Lai, J.-S., M. A. Cleary, and W. Herr. 1992. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev. 6:2058–2065.
   PubMedGoogle Scholar
• Li, P., X. He, M. R. Gerrero, M. Mok, A. Aggarwal, and M. G. Rosenfeld. 1993. Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7:2483–2496.
   PubMedGoogle Scholar
• O'Hare, P., and C. R. Goding. 1988. Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell 52:435–445.
   PubMedGoogle Scholar
• O'Hare, P., C. R. Goding, and A. Haigh. 1988. Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer-binding factor mediates specific induction of virus immediate early gene expression. EMBO J. 7:4231–4238.
   PubMedGoogle Scholar
• Pabo, C. O., A. K. Aggarwal, S. R. Jordan, L. J. Beamer, U. R. Obeysekare, and S. C. Harrison. 1990. Conserved residues make similar contacts in two repressor–operator complexes. Science 247:1210–1213.
   PubMedGoogle Scholar
• Pfaffle, R. W., G. E. DiMattia, J. S. Parks, M. R. Brown, J. M. Wit, M. Jansen, H. Van der Nat, J. L. Van den Brande, M. G. Rosenfeld, and H. A. Ingraham. 1992. Mutation of the POU-specific domain of Pit-1 and hypo-pituitarism without pituitary hypoplasia. Science 257:1118–1121.
   PubMed Web of Science ®Google Scholar
• Pomerantz, J. L., T. M. Kristie, and P. A. Sharp. 1992. Recognition of the surface of a homeo domain protein. Genes Dev. 6:2047–2057.
   PubMedGoogle Scholar
• Preston, C. M., M. C. Frame, and M. E. M. Campbell. 1988. A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell 52:425–434.
   PubMed Web of Science ®Google Scholar
• Pruijn, G. J. M., W. van Driel, R. T. van Miltenburg, and P. C. van der Vliet. 1987. Promoter and enhancer elements containing a conserved sequence motif are recognized by nuclear factor III, a protein stimulating adenovirus DNA replication. EMBO J. 6:3771–3778.
   PubMedGoogle Scholar
• Rodgers, D. W., and S. C. Harrison. 1993. The complex between phage 434 repressor DNA-binding domain and operator sites OR3: structural differences between consensus and non-consensus half-sites. Structure 1:227–240.
   PubMedGoogle Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
   PubMed Web of Science ®Google Scholar
• Sivaraja, M., M. C. Botfield, M. Mueller, A. Jansco, and M. A. Weiss. 1994. 3D-NMR studies of human B-cell transcription factor Oct-2. Biochemistry 33:9845–9855.
   PubMedGoogle Scholar
• Stern, S., and W. Herr. 1991. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev. 5:2555–2566.
   PubMedGoogle Scholar
• Stern, S., M. Tanaka, and W. Herr. 1989. The Oct-1 homeodomain directs formation of a multiprotein–DNA complex with the HSV transactivator VP16. Nature (London) 341:624–630.
   PubMed Web of Science ®Google Scholar
• Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods En-zymol. 185:60–89.
   PubMed Web of Science ®Google Scholar
• Sturm, R. A., T. Baumruker, B. R. Franza, Jr., and W. Herr. 1987. A 100-kD HeLa cell octamer binding protein (OBP100) interacts differently with two separate octamer-related sequences within the SV40 enhancer. Genes Dev. 1:1147–1160.
   PubMedGoogle Scholar
• Sturm, R. A., and W. Herr. 1988. The POU domain is a bipartite DNA-binding structure. Nature (London) 336:601–604.
   PubMed Web of Science ®Google Scholar
• Tanaka, M., U. Grossniklaus, W. Herr, and N. Hernandez. 1988. Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev. 2:1764–1778.
   PubMedGoogle Scholar
• Thompson, C. C., and S. L. McKnight. 1992. Anatomy of an enhancer. Trends Genet. 8:232–236.
   Google Scholar
• Verrijzer, C. P., M. J. Alkema, W. W. van Weperen, H. C. van Leeuwen, M. J. J. Strating, and P. C. van der Vliet. 1992. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 11:4993–5003.
   PubMedGoogle Scholar
• Verrijzer, C. P., A. J. Kal, and P. C. van der Vliet. 1990. The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA binding activity requires the POU-specific domain. Genes Dev. 4:1964–1974.
   PubMedGoogle Scholar
• Walker, S., S. Hayes, and P. O'Hare. 1994. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell 79:841–852.
   PubMedGoogle Scholar
• Xiao, P., and J. P. Capone. 1990. A cellular factor binds to the herpes simplex virus type 1 trans-activator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1. Mol. Cell. Biol. 10:4974–4977.
   PubMedGoogle Scholar
• Zoller, M. J., and M. Smith. 1983. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol. 100:468–500.
   PubMed Web of Science ®Google Scholar